Animet50 mg+0.50 mg+61.80 mg

Animet is indicated for the treatment and prevention of combined iron, folic acid, and zinc deficiency, particularly in situations of increased physiological demand.

Established / guideline-supported uses

• Iron-deficiency anemia: Treatment of documented iron-deficiency anemia, where the folic acid and zinc components support erythropoiesis and correct commonly co-existing micronutrient gaps.
• Prophylaxis in pregnancy and lactation: Prevention of iron, folic acid, and zinc deficiency in pregnant and breastfeeding women who have increased nutritional requirements and inadequate dietary intake. Folic acid supplementation in the periconceptional period and early pregnancy is separately well established for reducing the risk of fetal neural tube defects; this combination product is used as ongoing nutritional supplementation rather than as the specific high-dose neural-tube-defect regimen.
• Nutritional deficiency states: General correction of iron, folic acid, and zinc deficiency arising from poor dietary intake, malabsorption, chronic blood loss, or increased requirement (e.g., growth, convalescence).

Use of Animet should be guided by a physician, ideally with confirmation of iron/folate/zinc deficiency, since unnecessary supplementation of iron or zinc in individuals who are not deficient is not recommended.

Each dose (typically one capsule/tablet, formulation-dependent) of Carbonyl Iron + Folic Acid + Zinc Sulfate generally contains:

• Carbonyl iron equivalent to approximately 50 mg elemental iron
• Folic acid 500 micrograms (0.5 mg)
• Zinc sulfate monohydrate providing approximately 22.5 mg elemental zinc

Exact strengths vary by brand/manufacturer; refer to the specific product label for the precise composition.

Animet is a fixed-dose oral combination nutritional supplement that supplies elemental iron in the carbonyl iron form, together with folic acid and zinc sulfate. Carbonyl iron is a highly purified, elemental (metallic) form of iron produced as fine particles; it must be oxidized by gastric acid before it can be absorbed, which gives it a more gradual, self-limiting absorption profile and a notably wider margin of safety on accidental overdose compared with conventional ionic iron salts such as ferrous sulfate or ferrous fumarate.

Animet is commonly used for the prevention and treatment of iron, folic acid, and zinc deficiency, especially during pregnancy, lactation, and childhood/adolescent growth, and is available in Bangladesh under multiple brand names as capsules or tablets.

Animet belongs to the therapeutic class of hematinics and micronutrient/mineral-vitamin combination preparations — specifically, iron replacement therapy combined with a B-vitamin (folic acid) and a trace mineral (zinc) supplement.

Carbonyl Iron + Folic Acid + Zinc Sulfate combines three complementary micronutrients:

• Carbonyl iron: An elemental, nonionic form of metallic iron produced by thermal decomposition of iron pentacarbonyl into fine, highly pure spherical particles. It must first be converted to the ferrous (Fe2+) form by gastric hydrochloric acid before intestinal absorption via the divalent metal transporter in enterocytes. This acid-dependent, stepwise conversion limits the rate of iron release and absorption compared with pre-ionized ferrous salts, giving carbonyl iron comparable long-term efficacy for correcting iron-deficiency anemia with a substantially better safety margin in the event of accidental overdose.
• Folic acid: A synthetic form of vitamin B9 that is converted to its active metabolite, tetrahydrofolate, which is essential for DNA synthesis, cell division, and normal erythropoiesis (red blood cell maturation); it also supports normal fetal neural tube development when adequate levels are present around conception and in early pregnancy.
• Zinc sulfate: Supplies elemental zinc, a trace mineral cofactor for numerous enzymes involved in protein synthesis, immune function, wound healing, and growth.

Together, these components address the overlapping micronutrient deficiencies commonly seen in pregnancy, growth, and chronic blood loss.

Take Animet by mouth, preferably before meals with a full glass of water. If stomach upset occurs, it may be taken with food. Avoid concurrent intake with tea, coffee, milk, or calcium/dairy products, which can reduce iron absorption; space these by at least 1–2 hours from the dose.

Animet has the following clinically significant interactions:

• Tetracyclines and fluoroquinolones: The iron component chelates with these antibiotics, reducing absorption of both the antibiotic and iron; separate dosing by at least 2–3 hours.
• Levodopa, levothyroxine, methyldopa, penicillamine: Iron can reduce absorption and efficacy of these drugs; separate administration times.
• Antacids, calcium/dairy products, tea, and coffee: Reduce iron absorption when taken together; separate dosing.
• Antiepileptics (phenytoin, phenobarbital, primidone): Folic acid may lower plasma concentrations of these anticonvulsants with long-term co-administration, potentially reducing seizure control; clinical monitoring is advised.
• Oral bisphosphonates and penicillamine: Zinc and iron may reduce absorption of these agents; separate dosing by at least 2 hours.

Inform the prescribing physician of all concurrent medications before starting Animet.

Side effects with Animet are usually mild and gastrointestinal in nature:

• Common: Nausea, epigastric discomfort, constipation, diarrhea, dark/black stools (expected and harmless, due to unabsorbed iron), and occasional heartburn.
• Less common: Vomiting, anorexia, metallic taste, mild abdominal cramping.
• Rare: Hypersensitivity reactions (rash, itching); staining of teeth with liquid formulations (minimized by diluting and using a straw, not typically relevant to capsules/tablets).

Taking the dose with food (rather than on an empty stomach) can reduce gastrointestinal side effects, though this may slightly reduce iron absorption.

Animet is commonly used during pregnancy and lactation to meet increased iron, folic acid, and zinc requirements, and folic acid supplementation is well established as beneficial in this context. However, iron and zinc supplementation should ideally be based on documented or likely deficiency rather than used indiscriminately, and any supplementation regimen during pregnancy or breastfeeding should be used only if clearly needed, with the potential benefit weighed against potential risk, and only under the guidance of a physician. Excessive iron or zinc intake beyond recommended levels should be avoided in pregnancy and lactation. Consult a physician before use.

Use Animet with caution in the following situations:

• Peptic ulcer disease, inflammatory bowel disease, or diverticulitis: Iron can aggravate gastrointestinal irritation; use cautiously and under medical supervision.
• Renal impairment: Zinc is renally excreted and may accumulate with reduced renal function; monitor accordingly.
• Repeated blood transfusions: Patients receiving frequent transfusions are already at risk of iron overload and generally should not receive additional iron supplementation without specialist guidance.
• Chronic/excessive zinc intake: Prolonged use of zinc beyond recommended doses can cause copper deficiency, leading to anemia and neurological problems; do not exceed the recommended dose or duration without medical advice.
• Accidental ingestion by children: While carbonyl iron has a considerably wider safety margin than conventional ferrous iron salts on accidental overdose (due to its acid-dependent, slow-release absorption), iron-containing products remain a recognized cause of accidental poisoning in young children if a large quantity is ingested. Keep out of reach of children at all times.

Stool may become dark or black during treatment with Animet; this is expected and not a cause for concern unless accompanied by other symptoms such as abdominal pain or black, tarry, foul-smelling stools suggestive of gastrointestinal bleeding.

Carbonyl iron has a notably wider margin of safety than conventional ionic iron salts (such as ferrous sulfate) in acute overdose, because its absorption depends on slow, acid-mediated conversion in the stomach; there have been no well-documented reports of serious or fatal poisoning from carbonyl iron overdose alone. Nonetheless, large ingestions — and any overdose involving the zinc or folic acid components, or a combined/mixed-ingredient product — should always be treated as a medical emergency.

Possible features of overdose may include nausea, vomiting, abdominal pain, diarrhea, lethargy, and, with very large ingestions, more severe systemic effects. If overdose of Animet is suspected, especially in a child, seek immediate medical attention or contact a poison control center/emergency services right away; do not wait for symptoms to appear, and take the medicine container with you to the hospital.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Pregnant women: Animet is commonly used for iron, folic acid, and zinc supplementation during pregnancy under medical supervision; see Pregnancy and Lactation.

Breastfeeding women: Iron, folic acid, and zinc supplementation is commonly continued during lactation to meet increased maternal requirements; use as advised by a physician.

Children: Safety and efficacy of this specific fixed-dose combination have not been formally established in children; use only under pediatric medical supervision if prescribed, with attention to accidental-ingestion risk from all iron-containing products.

Elderly: No specific dose adjustment is generally required, but elderly patients with reduced renal function should be monitored for zinc accumulation, and those with gastrointestinal conditions should be monitored for tolerability.

Renal impairment: Use with caution due to risk of zinc accumulation; see Precautions and Warnings.

Duration of treatment with Animet depends on the indication and should be determined by a physician. For treatment of iron-deficiency anemia, therapy is typically continued for at least 3 months after correction of the anemia to replenish iron stores, subject to hemoglobin and ferritin response. For prophylactic use in pregnancy and lactation, it is generally continued throughout the relevant period as advised by the physician. Prolonged, high-dose use beyond the recommended duration — particularly of the zinc component — should be avoided without medical supervision due to the risk of copper deficiency.

Hematinic / Iron, Folic Acid and Zinc combination supplement

Carbonyl Iron + Folic Acid + Zinc Sulfate acts through the combined, complementary actions of its components: carbonyl iron is oxidized by gastric acid to the absorbable ferrous form and incorporated into hemoglobin to correct iron-deficiency anemia; folic acid is converted to tetrahydrofolate, essential for DNA synthesis and red blood cell maturation; and zinc sulfate supplies elemental zinc as a cofactor for numerous enzymatic and immune processes, growth, and wound healing.

The safety and efficacy of Animet as a fixed-dose combination have not been formally established in infants and young children. Where iron, folic acid, and zinc supplementation is indicated in children (e.g., documented deficiency, growth requirements), it is generally provided through age-appropriate, weight-based dosing of the individual components under pediatric medical supervision, rather than this adult-strength combination product. Because iron-containing preparations are a recognized cause of accidental pediatric poisoning if large quantities are ingested, all iron-containing products, including Animet, must be kept out of reach of children, and any suspected ingestion by a child requires immediate medical attention.